The human translation initiation multi-factor complex promotes methionyl-tRNAi binding to the 40S ribosomal subunit. by Sokabe, Masaaki et al.
UC Davis
UC Davis Previously Published Works
Title
The human translation initiation multi-factor complex promotes methionyl-tRNAi binding to 
the 40S ribosomal subunit.
Permalink
https://escholarship.org/uc/item/4tg108c4
Journal
Nucleic acids research, 40(2)
ISSN
0305-1048
Authors
Sokabe, Masaaki
Fraser, Christopher S
Hershey, John WB
Publication Date
2012
DOI
10.1093/nar/gkr772
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
The human translation initiation multi-factor
complex promotes methionyl-tRNAi binding
to the 40S ribosomal subunit
Masaaki Sokabe1,2, Christopher S. Fraser2 and John W. B. Hershey1,*
1Department of Biochemistry and Molecular Medicine and 2Department of Molecular and Cellular Biology,
University of California, Davis, CA 95616, USA
Received July 10, 2011; Revised September 1, 2011; Accepted September 2, 2011
ABSTRACT
The delivery of Met-tRNAi to the 40S ribosomal
subunit is thought to occur by way of a ternary
complex (TC) comprising eIF2, GTP and Met-tRNAi.
We have generated from purified human proteins a
stable multifactor complex (MFC) comprising eIF1,
eIF2, eIF3 and eIF5, similar to the MFC reported
in yeast and plants. A human MFC free of the
ribosome also is detected in HeLa cells and rabbit
reticulocytes, indicating that it exists in vivo.
In vitro, the MFC-GTP binds Met-tRNAi and
delivers the tRNA to the ribosome at the same rate
as the TC. However, MFC-GDP shows a greatly
reduced affinity to Met-tRNAi compared to that for
eIF2-GDP, suggesting that MFC components may
play a role in the release of eIF2-GDP from the
ribosome following AUG recognition. Since an
MFC–Met-tRNAi complex is detected in cell
lysates, it may be responsible for Met-tRNAi–40S
ribosome binding in vivo, possibly together with
the TC. However, the MFC protein components
also bind individually to 40S ribosomes, creating
the possibility that Met-tRNAi might bind directly
to such 40S-factor complexes. Thus, three distinct
pathways for Met-tRNAi delivery to the 40S riboso-
mal subunit are identified, but which one predomin-
ates in vivo remains to be elucidated.
INTRODUCTION
Recruitment and positioning of the initiator tRNA on the
small ribosomal subunit is required to initiate protein syn-
thesis. In eukaryotes, it is generally believed that the ini-
tiator tRNA is recruited to the 40S subunit surface as an
eIF2–GTP–Met-tRNAi ternary complex (TC). The TC is
further stabilized on the 40S subunit surface by the
presence of eIF1, eIF1A, eIF3 and eIF5. The resulting
43S pre-initiation complex then stably associates with an
mRNA via interactions with the cap-binding complex
located at the 50 end of the mRNA. During scanning
and recognition of the start codon, eIF2–GTP is
hydrolyzed in a reaction promoted by the GTPase-
activating protein, eIF5. GTP hydrolysis is completed by
phosphate release promoted by eIF1 dissociation upon
AUG recognition. Then, eIF2 is released as a GDP
form, leaving the Met-tRNAi in the P-site of the
ribosome. Finally, an 80S initiation complex is formed
by joining of a 60S ribosomal subunit and is ready to
synthesize the encoded protein. After the release of
eIF2–GDP from the ribosome, eIF2 is recycled to its
GTP form by the guanine nucleotide exchange
factor eIF2B and participates in another round of initi-
ation (1, 2).
Studies in Saccharomyces cerevisiae have shown that
eIF1, eIF2, eIF3 and eIF5 can form a stable multi-factor
complex (MFC) in the absence of 40S subunits in vitro and
in vivo by pull-down and sucrose gradient centrifugation
assays (3). The ribosome-free MFC detected in cell lysates
also was found to contain Met-tRNAi. Disruption of
interactions between MFC components inhibits protein
synthesis, implying a functional role for the formation of
the MFC during initiation. Extensive studies have
determined the precise nature of the interactions between
yeast MFC components (3–8). Specifically, affinity tag
pull-down assays indicate that eIF1, eIF3c and eIF5
form stable interactions with each other, and eIF5
bridges an interaction between eIF2 and eIF3 (3). An add-
itional contact between eIF3a and eIF2b has been
identified (9). Interaction domains within these compo-
nents have been identified and shown to form a minimal
core complex in vitro (3,8). Importantly, eIF5 is
recognized as the central component in forming the
MFC in S. cerevisiae (8). Attempts to study the MFC in
other systems have generated mixed results. The MFC
has been identified by pull-down assays using plant
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proteins (10), while studies using mammalian components
have identified only eIF5–eIF2b and eIF1–eIF3c inter-
actions in vitro (11,12).
It has been firmly established that interactions between
MFC components are important for protein synthesis ini-
tiation in yeast. It is unknown, however, whether the
MFC forms prior to 40S subunit binding or if it forms
on the surface of the 40S subunit in an ordered or random
fashion. It is possible that a pre-formed MFC functions to
deliver the initiator tRNA to the 40S subunit, but this has
never been tested. Moreover, whether an MFC can form
in mammalian cells is currently unknown. Using a native
gel electrophoresis assay, we have identified the presence
of a stable MFC that exists independently of the 40S
subunit in mammalian cell lysates. Using highly purified
components, we have been able to successfully reconsti-
tute the human MFC in vitro, confirming that the MFC is
conserved throughout evolution. Using our purified
system, we have investigated the role of a pre-formed
human MFC in delivering the initiator tRNA to the 40S
subunit. Interestingly, we show that eIF2 is able to bind to
40S subunits in the absence or presence of other MFC
components, creating the possibility that Met-tRNAi
delivery to the ribosome is direct rather than through
the TC. Thus, the findings suggest three possible
pathways for Met-tRNAi–40S binding: TC-mediated;
MFC-mediated; and direct.
MATERIALS AND METHODS
Preparation of proteins, ribosomes, tRNA and cell lysates
Endogenous eIF2, eIF3 and 40S ribosomal subunits were
purified from HeLa cell extracts as described previously
(13,14). Human initiator tRNAMet was in vitro transcribed
by T7 RNA polymerase and charged with either
non-labeled or 35S-labeled methionine using Escherichia
coli methionyl-tRNA synthetase as described previously
(15). The [35S]Met-tRNAi (15Ci/mmol) was stored at
80C in small aliquots with buffer containing 10mM
K acetate pH 5.2, 2mM MgCl2 and 1mM DTT. All re-
combinant proteins used here (human eIF1, eIF1A and
eIF5) were expressed as a fusion with a His-tag, maltose
binding protein (MBP) and TEV protease cleavage site on
the N-terminus by using modified pET-28c (Novagen) as
previously described for eIF1 and eIF1A (15).
Recombinant eIF5 was expressed and purified by similar
methods, as described in detail in Supplementary Data.
Rabbit reticulocyte lysate was from Green Hectares.
HeLa cells were grown in 10ml Dulbecco’s modified
Eagle’s medium (DMEM) media in a 37C CO2 incubator
for 60 h (70% confluence). Before harvesting, the cells
were incubated with fresh media for 20min to stimulate
translation, treated with 100 mg/ml cycloheximide for
3min and kept on ice. The cells were washed twice with
phosphate-buffered saline (PBS), and resuspended in 50 ml
buffer containing 20mM Tris–HCl pH 7.5, 80mM KCl,
1mM DTT, 2mM MgCl2, 5% glycerol, 0.1% Triton-X
and protease inhibitor cocktail (Roche), and lysed by
vortexing for 10min at 4C. The supernatant after
centrifugation at 30 000g for 15min was stored in small
aliquots at 80C.
Native gel electrophoresis
Binary and higher order protein complexes were formed
by mixing various combinations of eIF3, eIF2, eIF1
and/or eIF5 at 37C for 10min in 5 ml reaction buffer
(20mM Tris–HCl pH 8.1, 80mM KCl, 2mM DTT,
2mM MgCl2 and 5% glycerol). To test the effect of nu-
cleotides or Met-tRNAi, eIF2 was incubated with 1mM
GDPNP or GDP at 37C for 5min prior to the addition of
magnesium and 15 pmol of Met-tRNAi as indicated in the
figure legends. Clarified HeLa cell lysates (10ml, 0.5 OD260
units) and rabbit reticulocyte lysates (5ml, 0.4 OD260 unit)
were directly used for the analyses without any further
treatment. Reaction mixtures were loaded onto a
4% native polyacrylamide gel prepared in 10 cm 8 cm
glass slabs with electrophoresis buffer (50mM
Tris-borate pH 8.1) supplemented with 2mM MgCl2,
and run at 125V for 1.5–4 h at 4C. A wide (12mm)
sample comb was used to obtain better resolution. Gels
were stained with GelCode Blue stain (Thermo Scientific),
or analyzed by SDS–PAGE, western blotting, or reverse
transcription-polymerase chain reaction (RT-PCR). For
sodium dodecyl sulfate–polyacrylamide gel electrophor-
esis (SDS–PAGE) analysis, the native gel was negatively
stained with Zinc-imidazole (16). Each band was excised,
finely disrupted and shaken overnight at 4C in 200 ml
extraction buffer (25mM Tris, 250mM glycine and
0.1% SDS). Each band extract was filtered through a
Spin Cups paper filter (Pierce), TCA precipitated and
analyzed on an EZ-Run SDS gel (Fisher Scientific). Due
to its small size, eIF1 is not detected by Coomassie
staining, but its presence in the MFC band was con-
firmed by western blotting with anti-eIF1 specific to
its N-terminus (Santa Cruz Biotechnology). The blots
were imaged by using ECL plus/ECL Advance (GE
Healthcare) detection reagents and a fluorescent scanner/
CCD camera.
RT-PCR
The native gels of HeLa and rabbit reticulocyte lysates
were sliced, disrupted, extracted and subjected to
RT-PCR as described in detail in Supplementary Data.
Met-tRNAi filter binding assay
The nitrocellulose filter binding assay was done essentially
as described previously (17) (see Supplementary Data).
Met-tRNAi–40S ribosomal subunit binding rates
In the TC-mediated Met-tRNAi delivery assay, a TC
mixture (20 ml) was prepared by incubating 12 pmol of
eIF2 with 1mM GDPNP at 30C for 5min, followed by
the addition of 24 pmol of [35S]Met-tRNAi for 10min at
30C in reaction buffer (20mM Tris–HCl pH 7.0, 80mM
KCl, 2mM MgCl2, 2mM DTT and 5% glycerol). A 40S
ribosome mixture was prepared separately by incubating
12 pmol of eIF1, eIF1A, eIF5, eIF3 and 40S ribosomal
subunits in reaction buffer in a total volume of 20 ml.
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The two mixtures were further incubated separately at
25C for 10min, then mixed together at 25C to initiate
the reaction. The reaction was stopped at various time
points by loading a 4.5-ml aliquot onto a 2% polyacryl-
amide/0.5% agarose composite native gel (running at
125V at 0C) made with electrophoresis buffer (50mM
Tris-borate pH 8.1) supplemented with 2mM MgCl2
(18). As judged by the mobility of a xylene cyanol
marker dye, which shows a mobility similar to that of
the 40S ribosome under these conditions, it takes 30–40 s
for the complex to enter the gel after loading, suggesting
that the time resolution of this assay is at the level of
1min. Under these conditions, spontaneous deacylation
of free Met-tRNAi was measured to be <20% after
40min. Electrophoresis continued for another 40min
after loading the final time point (40min). The gel was
then fixed by soaking in 10% TCA for 15min at 4C,
dried on a polyvinylidene difluoride (PVDF) membrane
with a vacuum gel dryer at 4C for 1 h, heat dried for an
additional 30min and exposed to a phosphor screen over-
night. Because Met-tRNAi is easily deacylated and
diffuses when heating such a soft gel, consistent results
were obtained by vacuum drying the gel at 4C. The
amount of Met-tRNAi bound to 40S ribosomes was
estimated by the intensity of the radioactive band corres-
ponding to the 43S complex.
In the MFC-mediated delivery assay, the MFC mixture
was prepared as in the TC-mediated assay by combining
12 pmol of eIF1, eIF2, eIF3, eIF5, 1mM GDPNP and
24 pmol [35S]Met-tRNAi, while 40S ribosomal subunits
were mixed with eIF1A. The two mixtures were
combined, incubated and analyzed as described above.
In the direct binding assay, 40S subunits were mixed
with all the initiation factors involved and incubated for
10min, and then [35S]Met-tRNAi was added to initiate the
reaction.
GDP off-rate assay
eIF2 (18 pmol) was incubated with 0.24mCi [3H]GDP
(45Ci/mmol, Perkin Elmer) in reaction buffer (20mM
HEPES pH 7.5, 80mM KCl, 1mM DTT, 1mg/ml
creatine phosphokinase and 5% glycerol) without magne-
sium at 37C for 10min, and then incubated a further
10min at 37C with 1mM MgCl2 and with or without
30 pmol eIF5 in a total volume of 60 ml. The reaction
was initiated by adding 6000 pmol unlabeled GDP
(>1000 times excess) as a chase, and further incubated
at 37C. At each time point, an aliquot (8 ml) was
injected into 300 ml ice-cold stop buffer (reaction buffer
supplemented with 5mM MgCl2), filtered immediately
through an HAWP nitrocellulose membrane and washed
twice with 1ml ice-cold stop buffer. The radioactivity on
the dried membranes was measured with a liquid scintil-
lation counter. The resulting GDP dissociation curves
were fitted to a first order exponential decay to calculate
the off rates.
Factor binding to 40S ribosomes
For testing binding to 40S ribosomal subunits, reaction
mixtures were prepared essentially as described above by
using 2 pmol of 40S, 6 pmol of eIF1A and 6 pmol of the
other initiation factors in a total volume of 10 ml. Again,
1mM GDPNP or GDP, and 12 pmol Met-tRNAi were
included, where indicated, in the same manner as above.
Reaction mixtures were incubated for 10min at 37C,
loaded onto a 2% polyacrylamide/0.5% agarose compos-
ite native gel prepared with electrophoresis buffer (50mM
Tris-borate pH 8.1) supplemented with 2mM MgCl2 (18)
and run at 125V for 70min at 4C. The resulting gel was
stained by ethidium bromide and further analyzed by
western blotting.
RESULTS
The MFC is present in HeLa cell and rabbit
reticulocyte lysates
To test whether an MFC might exist independently of
ribosomes in mammalian cells, a HeLa cell lysate was sub-
jected to centrifugation to pellet nuclei and mitochondria,
then analyzed by native PAGE and immunoblotting with
anti-eIF3a antiserum. Using purified eIF3 as a marker
(Figure 1, lane 1), the lysate clearly generates an
immunoreactive band whose migration is significantly
slower than that of eIF3 (lane 3). Since ribosomes and
their complexes do not enter the gel under the conditions
used, the retardation of the anti-eIF3a reactive band
implies the presence of a ribosome-free complex in the
lysate. Unexpectedly, it appears that all of the eIF3 that
exists free of ribosomes in the lysate resides in this
complex, as no band corresponding to uncomplexed
eIF3 is detected. Immunoblotting with eIF5- and
eIF2a-specific antisera (lanes 4 and 5) confirms their
presence in the complex. To determine if the complex
also contains initiator tRNAi, the region of the gel con-
taining the complex was sliced horizontally into pieces,
extracted and subjected to RT-PCR to quantitate tRNAi
levels as described in ‘Materials and Methods’ section.
The yield of the specific product with each gel slice correl-
ates well with the position of the complex in the gel
(Figure 1), indicating that the complex contains
Met-tRNAi presumably bound to eIF2–GTP. These
results suggest that an MFC exists in human cells free
of ribosomes. A similar immunoblot analysis of a rabbit
reticulocyte lysate with anti-eIF3a, anti-eIF5 and
anti-eIF2a also detects a complex migrating with a
mobility slower than eIF3 but similar to that seen for
the MFC in HeLa cells (lanes 6–8). However, in this
case, a substantial amount of eIF3 is also found to
migrate as free eIF3; thus, the amount of MFC differs
in different cell types and/or in different physiological
states. It is interesting to note that in the reticulocyte
analyses, a portion of eIF2 migrates more slowly than
the MFC at a position corresponding to the band
reactive to anti-eIF2Be (lane 9), suggesting that this
complex is eIF2–eIF2B. Elucidation of the level and im-
portance of the eIF2–eIF2B complex and its possible de-
pendence on eIF2 phosphorylation will require further
experimentation.
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Formation of an MFC with purified human
initiation factors
To determine more convincingly if a human MFC
comprising eIF1, eIF2, eIF3 and eIF5 might form, we
constructed such a complex in vitro using purified
human factors. Endogenous eIF2 and eIF3 were purified
from HeLa cell cytosol, and recombinant eIF1 and eIF5
were expressed and isolated from bacteria, as described in
‘Materials and Methods’ section. Different combinations
of these purified factors were incubated together, followed
by analysis using native PAGE to detect their interactions.
Since eIF3 is the largest factor among the MFC compo-
nents (800 kDa), we initially tested whether adding the
other factors induces an eIF3 mobility shift, indicative
of complex formation. Adding eIF1, eIF2 and eIF5 se-
quentially to eIF3 results in a clear mobility shift at each
step (lanes 1–4 in Figure 2A). The shifted band in lane 4
was excised and subjected to SDS–PAGE and Coomassie
blue staining; bands corresponding to eIF2 and eIF5 are
seen in addition to those for eIF3, confirming their
presence in stoichiometric amounts (lane 5). Western
blotting of the shifted band in lane 4 with anti-eIF1 anti-
serum (lane 5, bottom) further confirms the presence of
eIF1 in the shifted complex. The results clearly indicate
that a human MFC comprising eIF1, eIF2, eIF3 and eIF5
can stably form in vitro. A dilution analysis indicates that
the human MFC is quite stable at concentrations above
300 nM (Figure 2B), suggesting that it can assemble at
physiological concentrations. Unexpectedly, the MFC
forms in both the presence and absence of GTP/GDP
and/or Met-tRNAi (data not shown). This implies that
the formation of the MFC is not sensitive to the nucleo-
tide bound state of eIF2.
Importantly, when the in vitro–generated MFC–
Met-tRNAi was analyzed together with cell lysates
(Figure 1, lane 2), it exhibited the same mobility as the
lysate complex containing eIF2, eIF3, eIF5 and
Met-tRNAi. This strongly supports the conclusion that
the ribosome-free complex seen in cell lysates is indeed an
MFC containing four initiation factors and Met-tRNAi.
To study MFC assembly in greater detail, binary inter-
actions between the four initiation factors were analyzed.
eIF2, eIF3, eIF5 and the resulting binary complexes
migrate as distinct bands in the gel and thus are easily
distinguished from one another (non-complexed eIF1
does not migrate into the gel under these conditions).
Accordingly, binary complexes are shown to form in
every possible combination (Figure 2C, and summarized
in Figure 2D). None of the binary complexes containing
eIF2 is affected significantly by the presence of GDP,
GDPNP and/or Met-tRNAi (data not shown). It should
be noted, however, that formation of the eIF1–eIF5
complex requires higher protein concentrations (10mM
of each protein compared to 1–2 mM for the other
complexes). Curiously, the shifted eIF3–eIF5 native gel
band contains a substoichiometric amount of eIF5
(Figure 2C, lane 10), even though the shift is almost
complete (compare lanes 6 and 8 in Figure 2C). This
suggests that this interaction is relatively weak and likely
dissociates during analysis but may somehow induce an
eIF3 conformation that persists even after dissociation.
Since the amount of eIF5 in the eIF2–eIF3–eIF5
trimeric complex is stoichiometric, but not in the eIF1–
eIF3–eIF5 and eIF3–eIF5 complexes (data not shown and
lane 10), it is likely that eIF5 is anchored to the MFC
mostly through its interaction with eIF2. We also find
that the eIF2–eIF3 complex starts to dissociate below
200–300 nM for each component (data not shown), thus
exhibiting a stability similar to that of the whole MFC
(Figure 2B). In contrast, the eIF1–eIF3 and eIF2–eIF5
binary complexes are quite stable even at 50 nM,
implying that the association of eIF2–eIF5 with eIF1–
eIF3 occurs through the eIF2–eIF3 interaction, which
may be the key interaction for MFC formation in humans.
Similar interactions are found between the components
of the yeast MFC, except that eIF1 binding to eIF2
appears to be much weaker (8). In addition, yeast eIF5
binding to yeast eIF3 appears to be much stronger than in
humans, with yeast eIF5 serving to mediate MFC
assembly as the core component (8). Taken together,
human and yeast MFC interaction models are similar,
eIF3a eIF5
1 2 3
HeLa lysate
eIF3 MFC
RRL
eIF3a
4 6RT-PCR
Yield
eIF5
7
Control
eIF2α
5
eIF2α
8
eIF2Bε
9
tRNAi
Figure 1. In vivo presence of the MFC shown by native gel electrophoresis of HeLa cell and rabbit reticulocyte lysates. Purified eIF3 (lane 1),
reconstituted MFC with Met-tRNAi (lane 2), HeLa cell lysate (lanes 3–5) and rabbit reticulocyte lysate (lanes 6–9) were subjected to native gel
electrophoresis as described in ‘Materials and Methods’ secton, and analyzed by western immunoblotting with anti-eIF3a (lanes 1, 3 and 6), anti-eIF5
(lanes 2, 4 and 7), anti-eIF2a (lanes 5 and 8) or anti-eIF2Be (lane 9) antiserum. Ribosomes and their complexes do not enter and stay at the top of
the gel and thus are clearly separated from ribosome-free factors under the condition used here. For the tRNAi specific RT-PCR, the lane of HeLa
cell lysate was horizontally sliced into pieces as shown by dashed lines, and their extracts were analyzed (see ‘Materials and Methods’ section).
The yields of the RT-PCR product are the means of two independent experiments, and errors shown are standard errors.
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though not identical, perhaps in large part due to the dif-
ference in eIF3 structures.
The eIF2–Met-tRNAi binding affinity in the presence of
GDP is greatly reduced by MFC components
Although the MFC can form in the absence of guanine
nucleotides and Met-tRNAi, we wished to determine
in vitro if it binds Met-tRNAi in a manner similar to
that for eIF2 alone. We first tested Met-tRNAi binding
affinities to eIF2–GDPNP with or without MFC compo-
nents using the standard nitrocellulose filter binding assay
(summarized in Table 1; see also Supplementary
Figure S1). Under our conditions, eIF2–GDPNP alone
binds Met-tRNAi with a dissociation constant of
35±2nM, which is in good agreement with a previously
reported value with the rabbit factor (28–47 nM) (17) and
is slightly weaker than that of yeast eIF2 (10 nM) (19). The
affinity seen with MFC–GDPNP (Kd=19±3nM) is
comparable to that for eIF2–GDPNP. Note that
saturating amounts of the other MFC components are
included throughout this experiment to reduce the possi-
bility of inefficient MFC formation at low eIF2 concen-
trations (see ‘Materials and Methods’ section). The results
A
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eIF3
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2
5
1
3
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SDS-PAGE
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Strong interaction
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Figure 2. In vitro reconstitution of human MFC with purified components. (A) Native gel analysis of protein complexes formed by mixing (in a total
of 5 ml) 5, 7.5, 10 and 10 pmol of eIF3, eIF2, eIF1 and eIF5, respectively, as indicated above the gel. Lane 5 shows the Coomassie-stained SDS gel
image generated from the excised band in lane 4, where the bands corresponding to each factors are identified. The presence of eIF1 in the band from
lane 4 was demonstrated by western immunoblotting of the native gel (lane 5, bottom). (B) Stability of the MFC shown by varying its concentration.
MFC components in the amounts defined in (A), lane 4, were mixed in different volumes to generate diluted mixtures, with eIF3 concentrations
ranging from 50 to 1000 nM. Following incubation at 25C for 10min, reactions were analyzed as in (A). (C) Binary interactions of MFC com-
ponents shown by native gels. eIF1 (10 pmol), eIF2 (7.5 pmol), eIF3 (5 pmol) and eIF5 (10 pmol) in lanes 3–9 (except 50 pmol each in lanes 1 and 2)
were combined in 5ml of reaction buffer as indicated above the gels. Complex formation was detected by band shifts and/or diminishing of the
monomer bands, and confirmed by SDS–PAGE/western immunoblotting. A representative SDS–PAGE analysis of the eIF3–eIF5 complex band is
shown (lane 10) (the eIF5 band is identified). Note that a gel with eIF1 alone is not shown, as this non-complexed protein does not enter the gel
under the conditions used here. (D) Component interaction models for the human and yeast MFC (this study and ref. 8). Each factor is indicated by
circled numbers. Bold lines indicate stable interactions, thin solid lines indicate moderate interactions and dashed lines indicate less stable inter-
actions. The key interaction line proposed to be important for MFC formation in each system is shown by arrows.
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indicate that the other three initiation factors in the MFC
have little effect on the ability of eIF2 in the GTP-state to
bind Met-tRNAi.
In light of this finding with GDPNP, we wished to de-
termine if the MFC and eIF2 are equally responsive to
GDP. The affinity of Met-tRNAi to eIF2 is 130-fold
decreased in the GDP state compared to the GTP state,
with a Kd value of 4600±170 nM. Human eIF2 therefore
displays a change in Met-tRNAi affinity between the GTP
and GDP states that is much stronger than observed for
its yeast counterpart, which shows only an 18-fold lower
affinity in the GDP state with a Kd of 180 nM (19).
Intriguingly, however, when we determined the
Met-tRNAi binding affinity with the MFC in the GDP
state, no Met-tRNAi binding is detected within the
range tested (Kd >> 6000 nM) (Table 1). To identify the
MFC component(s) responsible for this nucleotide-sensing
effect, we measured the Met-tRNAi binding affinities for
eIF2 binary complexes in the GDP state. Strikingly, we
find that the association of either eIF5 or eIF3 with eIF2–
GDP dramatically reduces its affinity to Met-tRNAi.
Curiously, eIF3 appears to have a much stronger effect,
comparable to that of the complete MFC (Supplementary
Figure S1). This result suggests that the release of eIF2–
GDP from the 40S ribosomal subunit following initiation
codon recognition is enhanced by eIF3 and eIF5 (see
‘Discussion’ section).
Because the binding of Met-tRNAi to eIF2 in the GDP
state is significantly affected by eIF3 and eIF5, we
wondered if human eIF5 might also serve as a
GDP-dissociation inhibitor (GDI) of eIF2, as recently
reported for yeast eIF5 (20). We therefore tested the
human eIF2–GDP dissociation rate in the presence and
absence of human eIF5. With eIF2 alone, the GDP off
rate at 1mM MgCl2 and 37
C is 6.6±0.1 103min1,
which is in the same range as the previously reported value
of 2.0 103min1 with the murine factor at 1mMMgCl2
and 0C (21). These values are two orders of magni-
tude slower than that reported for yeast eIF2 measured
at even higher magnesium and lower temperature
(1.2 101min1 at 2.9mM MgCl2 and 10C) (22,20).
When dissociation of GDP from eIF2 is measured in the
presence of eIF5, an off rate of 5.9±0.3 103min1 is
observed. We therefore detect very little if any inhibition
of GDP release by human eIF5. It is important to note,
however, that yeast eIF5 decreases GDP release by only
2-fold (20). Considering the high conservation of the con-
sensus motif responsible for GDI activity (20), it is
possible that the GDI activity of human eIF5 is stronger
under different experimental conditions. However, the
evidence to date indicates that human eIF5 does not
possess GDI activity, and thus differs from the yeast
system in this regard.
The MFC and TC promote Met-tRNAi binding to the
ribosome with equal rates
It is generally accepted that Met-tRNAi is delivered to the
40S ribosomal subunit as a TC. However, since the MFC
is present in cells and also binds Met-tRNAi, this raises
the possibility that Met-tRNAi binding involves the MFC
rather than, or in addition to, the TC. To test this, we set
up three different Met-tRNAi–40S binding reactions: (i) a
direct binding pathway in which Met-tRNAi binds
directly to the 40S subunit already complexed with all
additional factors (eIF1, eIF1A, eIF2–GDPNP, eIF3
and eIF5); (ii) a TC-mediated pathway in which the TC
is preformed and then added to 40S subunits already
carrying the other initiation factors; and (iii) an
MFC-mediated pathway in which the MFC is preformed
with Met-tRNAi and GDPNP and then is added to 40S
subunits containing only eIF1A. Note that the final com-
positions of the three reaction mixtures are identical and
only the orders of addition differ. Moreover, to reduce the
extent of possible dissociation of the preformed complexes
during the incubations, the concentrations of all the com-
ponents are kept above 300 nM at near-stoichiometric
levels. Met-tRNAi delivery rates to the 40S subunit were
monitored at each time point by loading a reaction aliquot
to a running native composite gel so that the resulting
43S complex is immediately separated from the other
components. Strikingly, almost 60% of input ribo-
somes bind Met-tRNAi in 30min in both the TC- and
MFC-mediated delivery pathways (Figure 3). In contrast,
only 20% binding of Met-tRNAi occurs after 30min in the
direct binding pathway. This indicates that both the MFC
and the TC stimulate the rate and degree of Met-tRNAi
binding when compared to non-complexed Met-tRNAi.
To ensure an efficient rate of delivery in this in vitro
assay, Met-tRNAi must therefore bind to eIF2 as part of
the TC or MFC prior to delivery to the 40S subunit.
The 40S ribosome binds initiation factors stably
To extend our MFC studies, we further investigated the
binding of individual components of the MFC to the 40S
subunit. Equilibrium binding of each component is
detected by native polyacrylamide–agarose composite gel
electrophoresis as described in ‘Materials and Methods’
section. Since eIF1A binds tightly to the 40S subunit
(15), it is routinely included in each binding experiment.
Gel analysis shows that each initiation factor individually
binds stably to the 40S ribosome (Figure 4), as confirmed
by band shifts (eIF2 and eIF3) and/or western blotting
(eIF1 and eIF5). Interestingly, eIF2 forms a stable 40S
complex with or without GDP/GDPNP/Met-tRNAi
under the conditions tested (Figure 4 and data not
shown). This result is unexpected, as its binding in the
Table 1. Summary of Met-tRNAi Kd values (nM)
GDPNP GDPa
eIF2 35±2 4600±170
MFC 19±3 N.D.
eIF2–eIF1 – 6100±140
eIF2–eIF5 – 21 000±1100
eIF2–eIF3 – N.D.
Values are means of two independent experiments. The errors shown
are standard errors.
N.D., not detected.
aThe values were calculated from the data from 188 to 3000 nM protein
concentration range.
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absence of Met-tRNAi is very weak when measured by
sucrose gradient centrifugation (23). We also find that
eIF2 and eIF5 bind stably to 40S ribosomal subunits in
the absence of eIF1A (data not shown). The fact that the
initiation factors bind stably to 40S ribosomal subunits in
the absence of Met-tRNAi raises the possibility that their
binding precedes Met-tRNAi binding, as has been
reported to occur in bacteria (24) and even more signifi-
cantly, in archaea (25). This view conflicts with the more
generally accepted mechanism that Met-tRNAi delivery is
mediated by the TC (see ‘Discussion’ section).
DISCUSSION
The ability to form a human MFC with purified proteins
suggests that such a complex may exist in cells free of the
ribosome. The MFC is stable at concentrations above
300 nM, but dissociates at more dilute concentrations
(Figure 2B). Since initiation factor concentrations in
HeLa cells are near 1000 nM (26), their concentrations
are sufficiently high to associate into a MFC without
involvement of the ribosome. Detection of the MFC–
Met-tRNAi complex in the HeLa cell cytoplasm by the
gentle native gel electrophoresis procedure (Figure 1)
supports the view that the MFC indeed exists in a
ribosome-free state in the cell. The finding that all of the
ribosome-free eIF3 is found in the MFC further enhances
the apparent importance of this complex.
Assuming that the presence of the MFC in the HeLa
cell and rabbit reticulocyte cytoplasm is due to its forma-
tion off the ribosome rather than to its dissociation from
the ribosome during the analysis, a free form of the MFC
suggests that it may play an important role in the delivery
of Met-tRNAi to the 40S ribosomal subunit. The MFC
efficiently binds Met-tRNAi in a reaction requiring GTP
(Supplementary Figure S1), and thus is comparable to the
TC. This raises the question of which complex, the TC or
the MFC, is responsible for bringing the Met-tRNAi to
the ribosome. Comparisons of Met-tRNAi delivery rates
by the TC and the MFC (Figure 3) show that both
complexes are equally efficient, and both stimulate the
rate over that obtained with uncomplexed initiator
tRNA. Under these conditions, no advantage in forming
the MFC is evident, but the results suggest that both the
TC and MFC participate in Met-tRNAi delivery to the
40S ribosomal subunit. This issue has been addressed in
yeast by measuring the cellular levels of TC and MFC
(27). The authors concluded that the TC forms first,
followed by the MFC-Met-tRNAi, which then binds to
the 40S subunit, but since no kinetic data were reported,
the actual pathway remains uncertain.
However, we also find that eIF2 and the other initiation
factors as well as the whole MFC bind stably to high
salt-washed 40S ribosomal subunits when assayed by
native composite gel electrophoresis (Figure 4). Much of
our understanding of the initiation pathway has been
based on results obtain by sucrose gradient centrifugation
analyses. However, detection of binding intermediates
requires that such complexes dissociate at very low rates,
sufficient to maintain association during the hours of cen-
trifugation, but which may not be physiologically relevant.
Thus, the failure to detect binding by such methods may
not reflect what is happening in cells. For example, eIF2 in
the absence of Met-tRNAi does not bind stably to 40S
ribosomes when examined by centrifugation methods,
yet forms a stable complex when assayed by native gel
electrophoresis. The latter finding suggests that its
binding affinity is sufficient to result in eIF2 binding to
40S subunits under physiological conditions.
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Figure 3. Rates of Met-tRNAi binding to 40S ribosomal subunits.
Met-tRNAi delivery rates involving direct binding (‘’ marks) and
TC- (solid circles) and MFC-mediated pathways (blank triangles)
were measured as described in ‘Materials and Methods’ section.
Values are the means of two independent experiments, and errors
shown are standard errors.
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Figure 4. Individual interactions between each MFC component and
40S-eIF1A are shown by composite native gel electrophoresis. Mixtures
containing 40S-eIF1A and the MFC components shown above the gel
were generated and analyzed as described in ‘Materials and Methods’
section. Binding was demonstrated by a band shift and/or subsequent
western blot analysis of the band with an antibody specific for the
initiation factor as shown at the bottom of each lane.
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If the individual initiation factors bind to the ribosome
faster than to one another, this would result in the forma-
tion of the MFC on the surface of the 40S ribosomal
subunit rather than in the ribosome-free state. The
stable binding of eIF2 and the other initiation factors to
the 40S ribosomal subunit raises the possibility that
Met-tRNAi binding occurs to such a 40S-factor complex
rather than through the TC- or MFC-mediated pathways
described above. Although our finding suggests that direct
binding of Met-tRNAi is slower than TC- or MFC-
mediated binding, this does not rule out direct binding
since the in vitro experimental conditions may not accur-
ately reflect those in intact cells. It is noteworthy that the
direct binding pathway is similar to what occurs in
bacteria and archaea, where sophisticated fluorescence
kinetic assays have shown that IF2/aIF2 binds first to
the 30S ribosomal subunit, followed by initiator tRNA
binding (24,25). Thus, the situation in eukaryotes
remains unclear, as our findings suggest three different
ways that the initiator tRNA could be delivered to the
40S ribosome. To resolve this important question in the
mammalian initiation pathway, detailed kinetic analyses
are required to determine which pathway is most
dominant in this regard. Real-time fluorescence assays
are needed to determine the association and dissociation
rates of eIF2 binding to Met-tRNAi, the 40S ribosome
and to other MFC components. In addition, rates must
be measured for Met-tRNAi binding to eIF2-GTP in
the free state, in the MFC and when bound to the 40S
ribosomal subunit. Although some of these binding
and dissociation rates have been determined (19), it
will be important to elucidate all of these reactions
under comparable conditions in order to resolve the
pathway of Met-tRNAi delivery to the 40S ribosomal
subunit.
Another important finding is that, compared to eIF2,
the MFC more severely discriminates Met-tRNAi
binding in the GDP state. Although the physiological
implication of this finding is not clear, one possibility is
that the MFC components or more simply eIF3 and
eIF5 promote eIF2–GDP dissociation from ribosome-
bound Met-tRNAi after start codon recognition and
GTP hydrolysis. A model has been proposed in which
eIF3, and possibly other initiation factors, may remain
bound to the 80S following initiation (28). This raises the
possibility that eIF2–GDP may dissociate as the free
factor rather than as part of the MFC. Alternatively,
eIF2–GDP may dissociate as a complex with eIF5, as
has been proposed to occur in yeast (29). Experiments
to measure the rapid association and dissociation rates of
individual initiation components with the 40S subunit
will therefore ultimately help reveal the true pathway of
Met-tRNAi delivery in human cells.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figure S1, Supplementary Methods and
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